IRIS Accounts Production v22.2.0.402 10984166 Board of Directors 1.10.20 30.9.21 30.9.21 false true false false true false Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure109841662020-09-30109841662021-09-30109841662020-10-012021-09-30109841662019-09-30109841662019-10-012020-09-30109841662020-09-3010984166ns16:EnglandWales2020-10-012021-09-3010984166ns15:PoundSterling2020-10-012021-09-3010984166ns11:Director12020-10-012021-09-3010984166ns11:PrivateLimitedCompanyLtd2020-10-012021-09-3010984166ns11:SmallEntities2020-10-012021-09-3010984166ns11:AuditExemptWithAccountantsReport2020-10-012021-09-3010984166ns11:SmallCompaniesRegimeForDirectorsReport2020-10-012021-09-3010984166ns11:SmallCompaniesRegimeForAccounts2020-10-012021-09-3010984166ns11:FullAccounts2020-10-012021-09-3010984166ns11:OrdinaryShareClass12020-10-012021-09-3010984166ns11:Director32020-10-012021-09-3010984166ns11:RegisteredOffice2020-10-012021-09-3010984166ns6:CurrentFinancialInstruments2021-09-3010984166ns6:CurrentFinancialInstruments2020-09-3010984166ns6:Non-currentFinancialInstruments2021-09-3010984166ns6:Non-currentFinancialInstruments2020-09-3010984166ns6:ShareCapital2021-09-3010984166ns6:ShareCapital2020-09-3010984166ns6:RetainedEarningsAccumulatedLosses2021-09-3010984166ns6:RetainedEarningsAccumulatedLosses2020-09-3010984166ns6:PlantMachinery2020-09-3010984166ns6:MotorVehicles2020-09-3010984166ns6:ComputerEquipment2020-09-3010984166ns6:PlantMachinery2020-10-012021-09-3010984166ns6:MotorVehicles2020-10-012021-09-3010984166ns6:ComputerEquipment2020-10-012021-09-3010984166ns6:PlantMachinery2021-09-3010984166ns6:MotorVehicles2021-09-3010984166ns6:ComputerEquipment2021-09-3010984166ns6:PlantMachinery2020-09-3010984166ns6:MotorVehicles2020-09-3010984166ns6:ComputerEquipment2020-09-3010984166ns6:WithinOneYearns6:CurrentFinancialInstruments2021-09-3010984166ns6:WithinOneYearns6:CurrentFinancialInstruments2020-09-3010984166ns6:BetweenOneTwoYearsns6:Non-currentFinancialInstruments2021-09-3010984166ns6:BetweenOneTwoYearsns6:Non-currentFinancialInstruments2020-09-3010984166ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2021-09-3010984166ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2020-09-3010984166ns11:OrdinaryShareClass12021-09-30
REGISTERED NUMBER: 10984166 (England and Wales)















Financial Statements for the Year Ended 30 September 2021

for

Innovo Denture Laboratories Ltd

Innovo Denture Laboratories Ltd (Registered number: 10984166)






Contents of the Financial Statements
for the Year Ended 30 September 2021




Page

Company Information 1

Chartered Certified Accountants' Report 2

Statement of Financial Position 3

Notes to the Financial Statements 5


Innovo Denture Laboratories Ltd

Company Information
for the Year Ended 30 September 2021







DIRECTORS: S J Coldicott
R McNamara





REGISTERED OFFICE: Meriden House
6 Great Cornbow
Halesowen
West Midlands
B63 3AB





REGISTERED NUMBER: 10984166 (England and Wales)





ACCOUNTANTS: Hamiltons Group Limited
Chartered Certified Accountants
Meriden House
6 Great Cornbow
Halesowen
West Midlands
B63 3AB

Chartered Certified Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Innovo Denture Laboratories Ltd

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Innovo Denture Laboratories Ltd for the year ended 30 September 2021 which comprise the Income Statement, Statement of Financial Position, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the Board of Directors of Innovo Denture Laboratories Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Innovo Denture Laboratories Ltd and state those matters that we have agreed to state to the Board of Directors of Innovo Denture Laboratories Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Innovo Denture Laboratories Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Innovo Denture Laboratories Ltd. You consider that Innovo Denture Laboratories Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Innovo Denture Laboratories Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Hamiltons Group Limited
Chartered Certified Accountants
Meriden House
6 Great Cornbow
Halesowen
West Midlands
B63 3AB


25 August 2022

Innovo Denture Laboratories Ltd (Registered number: 10984166)

Statement of Financial Position
30 September 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 51,312 913

CURRENT ASSETS
Inventories 5 2,385 2,110
Debtors 6 54,854 45,694
Cash at bank 24,004 53,706
81,243 101,510
CREDITORS
Amounts falling due within one year 7 66,898 47,988
NET CURRENT ASSETS 14,345 53,522
TOTAL ASSETS LESS CURRENT
LIABILITIES

65,657

54,435

CREDITORS
Amounts falling due after more than one
year

8

(36,667

)

(40,000

)

PROVISIONS FOR LIABILITIES (346 ) -
NET ASSETS 28,644 14,435

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 28,643 14,434
SHAREHOLDERS' FUNDS 28,644 14,435

Innovo Denture Laboratories Ltd (Registered number: 10984166)

Statement of Financial Position - continued
30 September 2021


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 August 2022 and were signed on its behalf by:





S J Coldicott - Director


Innovo Denture Laboratories Ltd (Registered number: 10984166)

Notes to the Financial Statements
for the Year Ended 30 September 2021

1. STATUTORY INFORMATION

Innovo Denture Laboratories Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in pound sterling, which is the functional currency of the business, and rounded to the nearest £.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

The Company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when the cost is incurred, if the replacement part is expected to provide incremental future benefits to the Company. The carrying amount of the replaced part is derecognised. Repairs and maintenance are charged to profit or loss during the period in which they are incurred.

Depreciation is charged so as to allocate the cost of the assets less their residual value over their estimated useful lives, on the following basis.

Computer equipment-25%on cost
Motor vehicles-25%reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Innovo Denture Laboratories Ltd (Registered number: 10984166)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2021

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2020 - 18 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 October 2020 - - 3,652 3,652
Additions 45,750 6,500 1,874 54,124
At 30 September 2021 45,750 6,500 5,526 57,776
DEPRECIATION
At 1 October 2020 - - 2,739 2,739
Charge for year 2,367 406 952 3,725
At 30 September 2021 2,367 406 3,691 6,464
NET BOOK VALUE
At 30 September 2021 43,383 6,094 1,835 51,312
At 30 September 2020 - - 913 913

5. INVENTORIES
2021 2020
£    £   
Stocks 2,385 2,110

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 49,481 25,339
Other debtors 5,373 10,961
Tax - 9,394
54,854 45,694

Innovo Denture Laboratories Ltd (Registered number: 10984166)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2021

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Bank loans and overdrafts 29,750 10,000
Trade creditors 7,715 10,685
Corporation tax 1,443 -
Social security and other taxes 11,788 19,562
pension control 538 -
Directors' accounts 964 4,842
Accruals and deferred income 14,700 2,899
66,898 47,988

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2021 2020
£    £   
Bank loans - 1-2 years 10,000 10,000
Bank loans - 2-5 years 26,667 30,000
36,667 40,000

9. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2021 2020
value: £    £   
1 Ordinary £1 1 1